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Flow-mediated regulation of vascular diameter is
observed in large arteries to small arterioles1-6 in
many species including man.5,7-9 This phenomenon
is of major importance in the regulation of vascula-
ture resistance during intestinal absorption,10 func-
tional hyperemia in skeletal muscle,11,12 and acute
collateral vessel dilation.3,13 Nitric oxide (NO) gen-
erally is believed to be a major contributor in flow-
mediated changes in vascular tone or resistance,10,14
including the dilation of collateral arteries.15,16
Although the participation of NO in flow-depen-
dent or shear stress-dependent regulation of vascular
diameter is supported by in vivo experiments and by
studies with isolated vessels and cultured cells, direct
in vivo measurements of NO concentration in resis-
tance arteries or arterioles associated with flow
changes are not available. Part of the problem is that
NO is difficult to measure in biologic systems; NO
is a gas with a short half-life that is produced in low
concentrations in vivo.17 Several methods of mea-
suring changes in NO concentration have been
developed. Archer17 provides an excellent review of
these methods and their relative strengths and weak-
nesses. Indirect means of determining changes in
NO concentration include measurements of cyclic
guanosine monophosphate, accumulation of nitrites,
or increases in citrulline concentration. More direct
methods of measuring changes in NO concentration
include chemiluminescence, diazotization assay,
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electron paramagnetic resonance, methemoglobin
spectrophotometer assay, gas chromatography, and
mass spectroscopy. Unfortunately, none of these
methods are well-suited to rapid in vivo analysis of
acute changes in NO concentration. Most in vivo
studies deduce the effects of NO on biologic systems
with inhibitors of NO synthase, such as Nw -nitro-L-
arginine-methyl ester (L-NAME). However, as
Archer17 reviews, these arginine analogs can have
hemodynamic effects that are independent of the
inhibition of NO synthase.
NO-specific electrodes recently have been devel-
oped and provide a means of direct measurement of
small changes in NO concentration that occur acute-
ly in biologic systems.17-19 These electrodes have
been used to evaluate changes in NO concentration
in cultured endothelial cells subjected to various
chemical stimuli and shear stress.18,20 NO-specific
electrodes also have been used in isolated mesenteric
vessels to evaluate NO release in response to maxi-
mal chemical stimulation in normotensive and
hypertensive rats.21 These electrodes recently have
been used in humans to measure NO concentration
in the hand veins under basal and stimulated condi-
tions.19 The purpose of the current study was to
show that NO concentration at the arterial wall is
increased with acute elevation of blood flow in small
mesenteric arteries. To our knowledge, ours is the
first report of direct in vivo measurement of flow-
mediated alteration of NO concentration in resis-
tance arteries.
METHODS
All animal procedures used in this study were
approved by the Animal Care and Use Committee of
the Indiana University School of Medicine.
Experiments were completed in nine male mongrel
dogs with an average weight of 25 kg. Animals were
anesthetized with 500 mg of pentobarbital intra-
venously, and anesthesia was maintained with contin-
uous intravenous propofol (Diprivan) infusion (20
mg/500 ml) titrated to effect by monitoring heart
rate, respiratory rate, and response to stimuli.
Supplemental pentobarbital injections (100 mg) also
were given as needed. All animals’ lungs were endo-
tracheally intubated, and respiration was maintained
with a ventilator. An arterial catheter was placed per-
cutaneously in the femoral artery and connected to a
transducer for continuous blood pressure monitoring.
A midline laparotomy was performed from the
sternum to the umbilicus. Electrocautery was used
to divide the skin, fascia, and peritoneum. The
cecum was identified, and approximately 30 to 40
cm of small bowel just proximal to the cecum was
exteriorized so that the mesenteric vessels were read-
ily accessible. The bowel was placed in plastic wrap
to maintain a moist environment. Warmed saline
solution was applied periodically to the bowel and
mesentery to maintain physiologic temperature and
a moist environment.
A 2-mm ultrasonic flow probe connected to a
flow meter (Transonics Systems Inc., Ithaca, N.Y.)
was applied to a mesenteric artery close to the cecal
Fig. 1. Schematic diagram of model used in these experiments. Three to eight adjacent
mesenteric arteries were occluded to double the flow in experimental artery. Arteries were
approximately 2 mm in size, and probe was 200 m m in diameter. Probe was aligned parallel to
experimental artery. No clinical evidence of ischemia was apparent in bowel supplied by ligat-
ed arteries.
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end of the exteriorized bowel. Slight dissection of
the peritoneum was usually necessary to allow place-
ment of the flow probe on the experimental artery.
Acoustical coupling jelly was added, and flow was
monitored continuously. Three to eight sequential
mesenteric arteries, which extended from this artery
in a proximal direction along the bowel (Fig. 1),
were sufficiently dissected to allow placement of a
vascular clamp on the artery without interfering with
the venous outflow or lymphatic drainage. These
arteries were occluded sequentially with vascular
clamps until blood flow in the experimental artery
was approximately doubled. The clamp on the artery
closest to the experimental artery then was removed
until the NO electrode was in place and baseline
measurements were obtained.
A NO-measuring system (ISO-NO meter and
200-m m–tip NO-specific electrode, World Precision
Instruments, Inc., Sarasota, Fla.) then was used. The
principles underlying this type of electrode and meter
are described elsewhere.22,23 Electrode calibration
was performed by means of the chemical generation
of NO according to the manufacturer’s instructions
and as previously described.20 In brief, NO concen-
tration was increased progressively by the addition of
measured volumes of KNO2 (50 m m) boluses to a
constantly stirred solution of H2SO4 (100 mm) and
KI (100 mm). Fig. 2 illustrates a typical calibration
plot of the NO electrode. Each point represents a
measurement made after a bolus of KNO2 was added
and after the electrode metering system had stabi-
lized at a new plateau. The average slope of the lin-
ear calibration curves was 1.16 ± 0.16 nA/m m, and
the correlation coefficient (r2) averaged 0.99 ± 0.01.
To make the in vivo measurements, the electrode tip
was placed initially in the mesenteric fat. After a sta-
ble measurement was obtained, the probe was placed
immediately adjacent to the outer arterial wall of the
experimental artery. Fig. 1 provides a schematic rep-
resentation of the placement of the flow probe, NO
electrode, and sites of occlusion.
All measurements, mean arterial pressure (MAP),
arterial flow, and NO electrode current, were digi-
tized with a computer data acquisition system and
saved to computer files as 1-second or 10-second
averages. After arterial measurements of NO elec-
trode current had been stable for at least 60 seconds,
the artery adjacent to the experimental artery was
clamped. Flow and NO concentration were mea-
sured simultaneously. A minimum of 60 seconds of
stable readings were obtained from each animal with
increased flow in the experimental artery. In most of
the dogs, this protocol of increasing blood flow by
arterial occlusion was repeated multiple times with
the same vessels.
In four of the nine animals, increased flow
through the experimental artery was maintained for
2 hours. Baseline NO concentrations then were
repeated by placing the NO electrode adjacent to the
experimental artery wall. To provide further evidence
that the electrodes were responding to changes in
NO concentration, L-NAME (10 mg/kg) then was
given intravenously, and continuous measurements
of flow, NO electrode current, and MAP were
obtained and recorded as described.
Once the experiments were completed, all data
were transferred to a spreadsheet (Microsoft Excel ver-
sion 5.0) for analysis. For each animal, averages of a
minimum of 30 seconds to a maximum of 90 seconds
were used. Unstable readings associated with move-
ment of the electrode or manipulation of the bowel or
mesentery were discarded. Statistical analysis was per-
formed with a software package (SigmaStat version
1.0, Jandel Scientific) with the paired t test. In one
case the signed rank test was used because the data
were not distributed normally. A p value of less than
0.05 was considered statistically significant. All results
are listed as the mean ± the standard error of the mean.
RESULTS
Nine mongrel dogs were used for this study. The
experimental protocol was developed, and technical
Fig. 2. A typical calibration profile of the NO electrode.
NO was generated chemically by addition of KNO2 to
solution that contained KI and H2SO4 according to the
equation: 2KNO2 + 2KI + 2H2SO4 + 2K2SO4 (2NO + I2
+ 2H20 +4K2SO4). Average slope of linear calibration
curves was 1.16 ± 0.16 nA/ m m, and correlation coeffi-
cient (r2) averaged 0.99 ± 0.01.
JOURNAL OF VASCULAR SURGERY
Volume 27, Number 4 Hyre, Unthank, and Dalsing 729
problems with the instrumentation and data acquisi-
tion systems were resolved with the first dog. Eight
animals were included in the statistical analysis of
changes in NO concentration associated with elevat-
ed flow. No clinical evidence of bowel ischemia was
found in any of the animals during these experi-
ments; no color changes were seen in the bowel, and
peristalsis was maintained. No intraoperative compli-
cations occurred.
In all of the animals, NO electrode current mea-
sured at the arterial wall was observed to increase as
arterial flow was elevated. Fig. 3 represents a typical
recording. NO electrode current was seen to increase
with flow and to remain elevated until the clamp was
released. As flow decreased after removal of the clamp,
NO electrode current fell to near preocclusion levels
and then decreased even more before stabilizing. This
protocol was repeated 18 times in nine dogs. The NO
electrode current increased in every animal the first
time that flow was elevated. Although the response
tended to be attenuated after the initial experimental
run, an increase was apparent in 15 of the 18 trials.
The average data for the first run in the eight dogs
for which computer records were available are pre-
sented in Fig. 4. Flow increased 5.5 ± 0.34 ml/min
from a baseline of 5.5 ± 0.47 ml/min (p = 0.001).
With elevated flow, NO electrode current increased
Fig. 3. Representative record from individual animal. NO electrode current (top) increased
when blood flow (bottom) was elevated acutely by arterial occlusion. When blood flow returned
to control levels, the NO electrode current decreased to preocclusion value and then dropped
even further. Falls to less-than-preocclusion levels were not observed in all animals.
Fig. 4. Animal averages of arterial flow (left panel) and
NO electrode current (right panel) before and after abrupt
elevation of blood flow (n = 8). Increase in NO electrode
current was small but consistent in all animals.
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0.15 ± 0.018 nA from 2.85 ± 0.198 nA (p = 0.02).
An elevation of NO electrode current associated with
the increased flow subsequent to the occlusion of
adjacent arteries occurred in all animals. When all 17
trials with computer records were considered, the NO
electrode current increased from 3.24 ± 0.58 to 3.41
± 0.68 nA (p = 0.039, with signed rank test). The
average NO electrode current of the tissue (2.68 ±
0.66 nA) was similar to that of the artery (2.85 ± 0.20
nA, p = 0.346) before experimental manipulation.
Fig. 5 shows the changes in MAP, arterial flow,
and NO electrode current that occurred in the four
animals that were given L-NAME intravenously.
MAP increased 11 ± 1.7 mm Hg from 142 ± 2.8
mm Hg (p = 0.04) after the administration of L-
NAME. Flow through the experimental mesenteric
artery decreased 2.0 ± 0.2 ml/min from 15.8 ± 1.5
ml/min after L-NAME (p = 0.03), and NO elec-
trode current decreased 0.23 ± 0.03 nA (p = 0.02).
For these four dogs, the decrease in the NO elec-
trode current measured at the arterial wall after
administration of L-NAME (0.24 ± 0.05 nA) tended
to be greater than the increase in NO electrode cur-
rent observed with abrupt elevation of flow (0.11 ±
0.02 nA; p = 0.053).
DISCUSSION
The electrode used in this study was sensitive to
NO as shown by chemical calibration (Fig. 2). The
arginine analogue, L-NAME, inhibits NO synthase,
including the endothelial isoform,24 and has been
documented to inhibit NO-dependent responses in
canines25-28 at doses less than or equal to the dosage
in this study. With the administration of L-NAME to
inhibit NO production, arterial pressure increased
and blood flow decreased (Fig. 5), which is consis-
tent with the inhibition of NO synthase and NO-
dependent vasodilatory tone. The decrease in the
NO electrode current measured after administration
of L-NAME (Fig. 5) provides evidence that the NO
electrode was responding to changes in NO concen-
tration at the arterial wall. Thus we believe that the
results clearly show that NO concentration at the
outer arterial wall is elevated as blood flow increases
through the mesenteric resistance arteries.
Arterial blood flow was elevated abruptly by cre-
ation of a collateral-vessel pathway in the vasculature
that perfused the terminal ileum as illustrated in Fig.
1. By this method, both the magnitude and duration
of the flow elevation can be controlled. We previ-
ously have used this model in rodents and found
that flow can be elevated more than 200% without
producing intestinal ischemia or affecting mean arte-
rial pressure or arterial pressure in the collateral ves-
sel.29 This finding is an important point in this study
because other methods of elevating arterial flow,
such as reactive hyperemia, alter arterial pressure and
produce transient ischemia, which may alter levels of
catecholamines or tissue metabolites that could
potentially influence electrode current and NO
release.17 In the current study, experimental blood
flow was elevated approximately 100% (Fig. 4). As
shown in Fig. 3, NO electrode current gradually
increased after the abrupt elevation of arterial flow
and ultimately was elevated approximately 0.15 nA
(Fig. 4). These observations support the role of NO
Fig. 5. Averages for mean arterial pressure (left panel), arterial flow (center panel), and NO
electrode current (right panel) for four animals before and after intravenous administration of
L-NAME. Average increase in blood pressure of 11 ± 1.7 mm Hg occurred within minutes of
administration of L-NAME.
as a major mediator of flow-induced vasodilation
and confirm conclusions drawn from prior in vivo
experiments with less direct means available to mea-
sure NO.30-32 Although our results show the flow-
mediated elevation of NO, our measurements may
underestimate significantly the actual NO concen-
tration within the arterial wall. Certainly some NO
produced by the endothelium will be degraded
before reaching the outer wall of the vessel. In addi-
tion, the portion of the electrode that is sensitive to
NO is a cylindrical region about 200 m m in diame-
ter and 2000 m m in length. This region of the elec-
trode was oriented parallel to the artery and placed
against the outer wall of the artery. Thus only a por-
tion of the sensitive element was immediately adja-
cent to the arterial wall. Higher concentrations
might have been obtained by placing the electrode
inside the vessel. However, this placement certainly
would have altered local hemodynamics and possibly
would have injured the endothelium and, conse-
quently, the NO-producing capability of the artery.
In addition, blood contains many agents that scav-
enge or destroy NO, so the intraluminal concentra-
tion possibly would not reflect the concentration to
which the vascular smooth muscle cells were
exposed. The concentration of the outer wall may
reflect most accurately the NO concentration
responsible for the regulation of arterial diameter
and resistance because the site of action of NO in
flow-mediated arterial dilation is the smooth muscle.
Although we believe that our measurements
underestimate the actual NO concentration, the
measurements are within the concentration range
reported by others. The changes that were observed
in NO concentration with elevated flow (150 ± 50
nm) in this in vivo study are similar to those report-
ed for cultured endothelial cells subjected to shear
stress (133 ± 9 nm),18 although many differences
exist between the two studies, including the magni-
tude of the change in shear forces. The maximal NO
concentration measured in human veins with chem-
ical stimulation has been reported to be approxi-
mately 250 nm.19 These measurements were taken
inside the vessel, but the concentrations are of the
same order of magnitude as we observed.
A major advantage of NO-sensitive microelec-
trodes is the temporal resolution that is possible.
Other methods provide only an average over time,
but transient changes can be detected with the NO
electrodes. In fact, Kanai et al.18 observed that NO
release from cultured endothelial cells exposed to
laminar flow indeed was elevated transiently. After
abrupt exposure to flow, NO concentration increased
at about 2 nm/sec for approximately 1 minute and
then decreased to baseline. When cells were exposed
continuously to flow, periodic responses were
observed at approximately 15-minute intervals.18 We
did not measure NO concentration longer than about
5 minutes, but we observed no evidence of periodic
fluctuation of NO concentration in our in vivo model.
In our experience, a plateau occurred in the NO elec-
trode within approximately 30 seconds and was main-
tained for the duration of the measurement.
However, we did observe that the increase in NO
electrode current sometimes dropped to less than pre-
occlusion levels when the clamp was removed (Fig. 3)
and tended to be attenuated when the occlusion pro-
tocol was repeated. These observations may suggest
that some inhibitory feedback mechanism, such as
that proposed by Buga et al.,33 exists to suppress NO
production and that this inhibition becomes most
apparent when the initial stimulus is removed.
Several studies, including our current report,
have shown the stimulated release of NO in vivo,19,34
and yet the basal release of NO remains controversial.
Changes in systemic pressure and regional blood
flow and resistance after administration of inhibitors
of NO production16,35 suggest that a basal release of
NO exists in vivo, but these inhibitors may have non-
specific effects.17 No basal NO production was
detected by NO electrodes in human veins.19 In our
study, we did not detect a significant difference
between the NO electrode current in mesenteric fat
and the NO electrode current at the outer arterial
wall in resting arteries. However, the increase in NO
electrode current during abrupt elevation of flow
tended to be less than the decrease observed after
administration of L-NAME, which suggests that a
basal release of NO exists. The levels of NO present
under basal conditions may be too low or too vari-
able20 to be detected by the current NO electrodes.
Our study and many previous reports provide
evidence that alterations in blood flow or in the
associated shear forces modulate levels of NO in
the arterial wall. The use of NO-specific electrodes
to directly measure in vivo changes in NO concen-
tration that occur with altered flow in resistance
vessels provides an exciting opportunity to further
investigate this important aspect of vasoregulation.
Studies in diseased animals characterized by
endothelial dysfunction, including diabetes, hyper-
tension, and hyperlipidemia, especially are needed.
Application of this technique to human vessels
already has been done and could be expanded.
Future investigations in humans and in diseased
vessels should provide a greater understanding of
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the physiologic and pathophysiologic role of NO in
vascular regulation and eventually may aid in diag-
nostic or therapeutic decision-making in diseases in
which collateral vessels may be extremely impor-
tant, such as cholesterol emboli or diabetes.
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